{
  "responseHeader":{
    "status":0,
    "QTime":0,
    "params":{
      "q":"iati_identifier:GB-GOV-10-EDCTP3",
      "fl":"*",
      "format":"json"
    }
  },
  "response":{
    "numFound":1,
    "start":0,
    "numFoundExact":true,
    "docs":[{
      "default-currency":"GBP",
      "default_currency":"GBP",
      "hierarchy":1,
      "humanitarian":false,
      "last-updated-datetime":"2026-03-25T11:12:22.540Z",
      "last_updated_datetime":"Wed Mar 25 11:12:22 UTC 2026",
      "last_updated_datetime_f":"2026-03-25T11:12:22.540Z",
      "lang":"en",
      "default_lang":"en",
      "iati-identifier":"GB-GOV-10-EDCTP3",
      "iati_identifier":"GB-GOV-10-EDCTP3",
      "reporting-org.ref":"GB-GOV-10",
      "reporting_org_ref":"GB-GOV-10",
      "reporting-org.type":"10",
      "reporting_org_type_code":"10",
      "reporting-org.narrative":["UK - Department of Health and Social Care (DHSC)"],
      "reporting_org_narrative":["UK - Department of Health and Social Care (DHSC)"],
      "reporting-org.narrative.lang":[" "],
      "title.narrative":["European and Developing Countries Clinical Trials Partnership (EDCTP) phase III"],
      "title_narrative":["European and Developing Countries Clinical Trials Partnership (EDCTP) phase III"],
      "title_narrative_text":["European and Developing Countries Clinical Trials Partnership (EDCTP) phase III"],
      "title.narrative.lang":[" "],
      "title_narrative_lang":[" "],
      "description.type":["1","2"],
      "description_type":["1","2"],
      "description.narrative":["The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provides funding to the Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking which works to deliver new solutions to reduce the burden of poverty-related infectious diseases in sub-Saharan Africa and to strengthen research capacities to prepare and respond to re-emerging infectious diseases. Global Health EDCTP3 builds on EDCTP Phase 2, which NIHR has been contributing to since 2016 (GB-GOV-10-EDCTP2). As EDCTP transitions to Global Health EDCTP3, calls under the new work packages will support further clinical research and training in sub-Saharan Africa.","The EU Strategic Research and Innovation Agenda (SRIA) for the Global Health EDCTP3 programme has two programmatic aims and five specific objectives for the 2021 to 2031 work programme. The programme aims to: (1) reduce the individual, social, and economic burdens of infectious diseases in sub-Saharan Africa through the development and uptake of new or improved interventions and (2) increase health security in sub-Saharan Africa and globally, particularly in the context of environmental change and the climate crisis, by reducing the risk of outbreaks and pandemics, and enhancing national and regional capacity to address antimicrobial resistance. Five specific objectives: 1) Advance biomedical interventions towards improved overall health, 2) Research capacity development, 3) Enhance coordination, 4) Strengthen capacity for epidemic preparedness and 5) build partnerships and strategic alliances. "],
      "description_narrative":["The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provides funding to the Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking which works to deliver new solutions to reduce the burden of poverty-related infectious diseases in sub-Saharan Africa and to strengthen research capacities to prepare and respond to re-emerging infectious diseases. Global Health EDCTP3 builds on EDCTP Phase 2, which NIHR has been contributing to since 2016 (GB-GOV-10-EDCTP2). As EDCTP transitions to Global Health EDCTP3, calls under the new work packages will support further clinical research and training in sub-Saharan Africa.","The EU Strategic Research and Innovation Agenda (SRIA) for the Global Health EDCTP3 programme has two programmatic aims and five specific objectives for the 2021 to 2031 work programme. The programme aims to: (1) reduce the individual, social, and economic burdens of infectious diseases in sub-Saharan Africa through the development and uptake of new or improved interventions and (2) increase health security in sub-Saharan Africa and globally, particularly in the context of environmental change and the climate crisis, by reducing the risk of outbreaks and pandemics, and enhancing national and regional capacity to address antimicrobial resistance. Five specific objectives: 1) Advance biomedical interventions towards improved overall health, 2) Research capacity development, 3) Enhance coordination, 4) Strengthen capacity for epidemic preparedness and 5) build partnerships and strategic alliances. "],
      "description_narrative_text":["The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provides funding to the Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking which works to deliver new solutions to reduce the burden of poverty-related infectious diseases in sub-Saharan Africa and to strengthen research capacities to prepare and respond to re-emerging infectious diseases. Global Health EDCTP3 builds on EDCTP Phase 2, which NIHR has been contributing to since 2016 (GB-GOV-10-EDCTP2). As EDCTP transitions to Global Health EDCTP3, calls under the new work packages will support further clinical research and training in sub-Saharan Africa.","The EU Strategic Research and Innovation Agenda (SRIA) for the Global Health EDCTP3 programme has two programmatic aims and five specific objectives for the 2021 to 2031 work programme. The programme aims to: (1) reduce the individual, social, and economic burdens of infectious diseases in sub-Saharan Africa through the development and uptake of new or improved interventions and (2) increase health security in sub-Saharan Africa and globally, particularly in the context of environmental change and the climate crisis, by reducing the risk of outbreaks and pandemics, and enhancing national and regional capacity to address antimicrobial resistance. Five specific objectives: 1) Advance biomedical interventions towards improved overall health, 2) Research capacity development, 3) Enhance coordination, 4) Strengthen capacity for epidemic preparedness and 5) build partnerships and strategic alliances. "],
      "description.narrative.lang":[" "," "],
      "description_narrative_lang":[" "," "],
      "participating-org.ref":["GB-GOV-10","GB-GOV-10","GB-GOV-10","NL-KVK-60471700","NL-KVK-60471700"],
      "participating_org_ref":["GB-GOV-10","GB-GOV-10","GB-GOV-10","NL-KVK-60471700","NL-KVK-60471700"],
      "participating-org.role":["1","2","3","4","4"],
      "participating_org_role":["1","2","3","4","4"],
      "participating-org.type":["10","10","10","30","30"],
      "participating_org_type":["10","10","10","30","30"],
      "participating-org.narrative":["UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)"],
      "participating_org_narrative":["UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)"],
      "participating_org_narrative_text":["UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)"],
      "participating-org.narrative.lang":[" "," "," "," "," "],
      "participating_org_narrative_lang":[" "," "," "," "," "],
      "activity-status.code":"2",
      "activity_status_code":"2",
      "activity-date.iso-date":["2023-12-08T00:00:00Z","2023-12-08T00:00:00Z","2027-03-31T00:00:00Z"],
      "activity_date_iso_date":["2023-12-08T00:00:00Z","2023-12-08T00:00:00Z","2027-03-31T00:00:00Z"],
      "activity-date.type":["1","2","3"],
      "activity_date_type":["1","2","3"],
      "contact-info.type":["1"],
      "contact_info_type":["1"],
      "contact-info.organisation.narrative":["UK - Department of Health and Social Care (DHSC)"],
      "contact_info_organisation_narrative":["UK - Department of Health and Social Care (DHSC)"],
      "contact_info_organisation_narrative_text":["UK - Department of Health and Social Care (DHSC)"],
      "contact-info.organisation.narrative.lang":[" "],
      "contact_info_organisation_narrative_lang":[" "],
      "contact-info.department.narrative":["Science, Research and Evidence"],
      "contact_info_department_narrative":["Science, Research and Evidence"],
      "contact_info_department_narrative_text":["Science, Research and Evidence"],
      "contact-info.department.narrative.lang":[" "],
      "contact_info_department_narrative_lang":[" "],
      "contact-info.person-name.narrative":["Global Health Research Programme"],
      "contact_info_person_name_narrative":["Global Health Research Programme"],
      "contact_info_person_name_narrative_text":["Global Health Research Programme"],
      "contact-info.person-name.narrative.lang":[" "],
      "contact_info_person_name_narrative_lang":[" "],
      "contact-info.email":["GlobalHealthResearch@dhsc.gov.uk"],
      "contact_info_email":["GlobalHealthResearch@dhsc.gov.uk"],
      "contact-info.website":["https://www.nihr.ac.uk/funding-and-support/global-health-research/"],
      "contact_info_website":["https://www.nihr.ac.uk/funding-and-support/global-health-research/"],
      "contact-info.mailing-address.narrative":["7th Floor South Wing, 39 Victoria Street, London, SW1H 0EU"],
      "contact_info_mailing_address_narrative":["7th Floor South Wing, 39 Victoria Street, London, SW1H 0EU"],
      "contact_info_mailing_address_narrative_text":["7th Floor South Wing, 39 Victoria Street, London, SW1H 0EU"],
      "contact-info.mailing-address.narrative.lang":[" "],
      "contact_info_mailing_address_narrative_lang":[" "],
      "activity-scope.code":"2",
      "activity_scope_code":"2",
      "recipient-region.code":["298"],
      "recipient_region_code":["298"],
      "recipient-region.vocabulary":["1"],
      "recipient_region_vocabulary":["1"],
      "sector.code":["12182"],
      "sector_code":["12182"],
      "sector.percentage":[100.0],
      "sector_percentage":[100.0],
      "sector.vocabulary":["1"],
      "sector_vocabulary":["1"],
      "sector.narrative":["Medical research"],
      "sector_narrative":["Medical research"],
      "sector_narrative_text":["Medical research"],
      "sector.narrative.lang":[" "],
      "sector_narrative_lang":[" "],
      "tag.code":["RI"],
      "tag_code":["RI"],
      "tag.vocabulary":["99"],
      "tag_vocabulary":["99"],
      "tag.vocabulary-uri":["https://devtracker.fcdo.gov.uk/custom-codes"],
      "tag_vocabulary_uri":["https://devtracker.fcdo.gov.uk/custom-codes"],
      "tag.narrative":["Research and Innovation"],
      "tag_narrative":["Research and Innovation"],
      "tag_narrative_text":["Research and Innovation"],
      "tag.narrative.lang":[" "],
      "tag_narrative_lang":[" "],
      "collaboration-type.code":"1",
      "collaboration_type_code":"1",
      "default-flow-type.code":"10",
      "default_flow_type_code":"10",
      "default-finance-type.code":"110",
      "default_finance_type_code":"110",
      "default-aid-type.code":["C01"],
      "default_aid_type":["C01"],
      "default_aid_type_category_code":["C01"],
      "default_aid_type_code":["C01"],
      "default-tied-status.code":"5",
      "default_tied_status_code":"5",
      "capital-spend.percentage":100.0,
      "capital_spend_percentage":100.0,
      "document-link.format":["application/pdf","text/html","text/html","text/html","text/html","text/html","text/html","application/pdf","application/pdf","application/pdf","application/pdf"],
      "document_link_format":["application/pdf","text/html","text/html","text/html","text/html","text/html","text/html","application/pdf","application/pdf","application/pdf","application/pdf"],
      "document-link.url":["https://drive.google.com/file/d/1gKjBMegVAsBuyERmpqiDEgK0C-dBGmxF/view?usp=drive_link","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2023-01-02?isExactMatch=true&status=31094501,31094502,31094503&callIdentifier=HORIZON-JU-GH-EDCTP3-2023-01&order=DESC&pageNumber=1&pageSize=50&sortBy=startDate","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-01-05-two-stage","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-01-06-two-stage","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-02-01-two-stage","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-mpox","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2025-01-NTD-03-two-stage?order=DESC&pageNumber=1&pageSize=50&sortBy=startDate&keywords=edctp3&isExactMatch=true&status=31094501","https://drive.google.com/file/d/1BZWPFcre_19ai3P9xy8nsVDF8dUQJh2J/view?usp=drive_link","https://drive.google.com/open?id=1PdErJJpupm0rsFpEHypFzPd01LQ5LHLK&usp=drive_copy","https://drive.google.com/open?id=1wCyNw0EOM066OHrHcz1ITfLy3AezaK9K&usp=drive_copy","https://drive.google.com/file/d/1mles5md6uaJ9V1fuDBHrinEf9EY3LEVl/view?usp=drive_link"],
      "document_link_url":["https://drive.google.com/file/d/1gKjBMegVAsBuyERmpqiDEgK0C-dBGmxF/view?usp=drive_link","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2023-01-02?isExactMatch=true&status=31094501,31094502,31094503&callIdentifier=HORIZON-JU-GH-EDCTP3-2023-01&order=DESC&pageNumber=1&pageSize=50&sortBy=startDate","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-01-05-two-stage","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-01-06-two-stage","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-02-01-two-stage","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-mpox","https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2025-01-NTD-03-two-stage?order=DESC&pageNumber=1&pageSize=50&sortBy=startDate&keywords=edctp3&isExactMatch=true&status=31094501","https://drive.google.com/file/d/1BZWPFcre_19ai3P9xy8nsVDF8dUQJh2J/view?usp=drive_link","https://drive.google.com/open?id=1PdErJJpupm0rsFpEHypFzPd01LQ5LHLK&usp=drive_copy","https://drive.google.com/open?id=1wCyNw0EOM066OHrHcz1ITfLy3AezaK9K&usp=drive_copy","https://drive.google.com/file/d/1mles5md6uaJ9V1fuDBHrinEf9EY3LEVl/view?usp=drive_link"],
      "document-link.title.narrative":["EDCTP Phase 2 and 3 2023-2025 Annual Review","EDCTP3 Call for Proposals Tender","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 Strategy","Memorandum of Understanding","Memorandum of Understanding","Memorandum of Understanding EDCTP 2+3"],
      "document_link_title_narrative":["EDCTP Phase 2 and 3 2023-2025 Annual Review","EDCTP3 Call for Proposals Tender","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 Strategy","Memorandum of Understanding","Memorandum of Understanding","Memorandum of Understanding EDCTP 2+3"],
      "document_link_title_narrative_text":["EDCTP Phase 2 and 3 2023-2025 Annual Review","EDCTP3 Call for Proposals Tender","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 EU Funding and Tenders Document","EDCTP3 Strategy","Memorandum of Understanding","Memorandum of Understanding","Memorandum of Understanding EDCTP 2+3"],
      "document-link.title.narrative.lang":[" "," "," "," "," "," "," "," "," "," "," "],
      "document_link_title_narrative_lang":[" "," "," "," "," "," "," "," "," "," "," "],
      "document-link.category.code":["A07","A08","A02","A05","A10","A02","A10","A02","A10","A02","A10","A02","A10","A02","A10","A02","A02","A09","A04","A09","A04","A09","A04"],
      "document_link_category_code":["A07","A08","A02","A05","A10","A02","A10","A02","A10","A02","A10","A02","A10","A02","A10","A02","A02","A09","A04","A09","A04","A09","A04"],
      "document-link.language.code":["en","en","en","en","en","en","en","en","en","en","en"],
      "document_link_language_code":["en","en","en","en","en","en","en","en","en","en","en"],
      "document-link.document-date.iso-date":["2025-05-26T00:00:00Z","2023-05-10T00:00:00Z","2024-01-18T00:00:00Z","2024-01-18T00:00:00Z","2024-01-18T00:00:00Z","2024-01-18T00:00:00Z","2015-01-30T00:00:00Z","2022-01-12T00:00:00Z","2023-12-08T00:00:00Z","2023-09-21T00:00:00Z","2023-12-08T00:00:00Z"],
      "document_link_document_date_iso_date":["2025-05-26T00:00:00Z","2023-05-10T00:00:00Z","2024-01-18T00:00:00Z","2024-01-18T00:00:00Z","2024-01-18T00:00:00Z","2024-01-18T00:00:00Z","2015-01-30T00:00:00Z","2022-01-12T00:00:00Z","2023-12-08T00:00:00Z","2023-09-21T00:00:00Z","2023-12-08T00:00:00Z"],
      "related-activity.ref":["GB-GOV-10-EDCTP3_GlobalHealth","GB-GOV-10-EDCTP3_PM"],
      "related_activity_ref":["GB-GOV-10-EDCTP3_GlobalHealth","GB-GOV-10-EDCTP3_PM"],
      "related-activity.type":["2","2"],
      "related_activity_type":["2","2"],
      "conditions.attached":false,
      "conditions_attached":"0",
      "reporting-org.type.name":"Government",
      "reporting_org_type_name":"Government",
      "recipient-region.name":["Africa, regional"],
      "recipient_region_name":["Africa, regional"],
      "default-aid-type.name":["Project-type interventions"],
      "default_aid_type_category_name":["Project-type interventions"],
      "tag.vocabulary.name":["Reporting Organisation"],
      "title.narrative.first":"European and Developing Countries Clinical Trials Partnership (EDCTP) phase III",
      "title_narrative_first":"European and Developing Countries Clinical Trials Partnership (EDCTP) phase III",
      "activity-date.start-planned":"2023-12-08T00:00:00Z",
      "activity_date_start_planned":"Fri Dec 08 00:00:00 UTC 2023",
      "activity_date_start_planned_f":"2023-12-08T00:00:00Z",
      "activity-date.common.start":"2023-12-08T00:00:00Z",
      "activity_date_start_common":"Fri Dec 08 00:00:00 UTC 2023",
      "activity_date_start_common_f":"2023-12-08T00:00:00Z",
      "activity-date.start-actual":"2023-12-08T00:00:00Z",
      "activity_date_start_actual":"Fri Dec 08 00:00:00 UTC 2023",
      "activity_date_start_actual_f":"2023-12-08T00:00:00Z",
      "activity-date.end-planned":"2027-03-31T00:00:00Z",
      "activity_date_end_planned":"Wed Mar 31 00:00:00 UTC 2027",
      "activity_date_end_planned_f":"2027-03-31T00:00:00Z",
      "activity-date.common.end":"2027-03-31T00:00:00Z",
      "activity_date_end_common":"Wed Mar 31 00:00:00 UTC 2027",
      "activity_date_end_common_f":"2027-03-31T00:00:00Z",
      "activity-status.text":"Implementation",
      "activity_status_text":"Implementation",
      "dataset.id":"bce0347a-c08e-4d93-86ce-c44d7adc5c93",
      "dataset_iati_id":"bce0347a-c08e-4d93-86ce-c44d7adc5c93",
      "dataset.name":"dhsc-activities-ghr",
      "dataset_name":"dhsc-activities-ghr",
      "dataset.extras.iati_version":"2.03",
      "dataset.resources.hash":"5a2fa4a2f378e3034bb8e88e541b337f92b20e0f",
      "dataset.resources.url":"https://dhsc-govuk.github.io/iati-oda-spending-metadata/dhsc-activities-ghr.xml",
      "activity-date.quarter":[4,4,1],
      "document-link.document-date.quarter":[2,2,1,1,1,1,1,1,4,3,4],
      "document-link.category-codes-combined":["A07,A08,A02,A05","A10,A02","A10,A02","A10,A02","A10,A02","A10,A02","A10,A02","A02","A09,A04","A09,A04","A09,A04"],
      "child-aggregation.budget.value":3.008838578E7,
      "child_aggregation_budget_value":3.008838578E7,
      "activity-plus-child-aggregation.budget.value":3.008838578E7,
      "activity_plus_child_aggregation_budget_value":3.008838578E7,
      "child-aggregation.budget.currency":"USD",
      "child_aggregation_budget_currency":"USD",
      "activity-plus-child-aggregation.budget.currency":"USD",
      "activity_plus_child_aggregation_budget_currency":"USD",
      "child-aggregation.budget.value-usd":3.805277574369502E7,
      "child_aggregation_budget_value_usd":3.805277574369502E7,
      "activity-plus-child-aggregation.budget.value-usd":3.805277574369502E7,
      "activity_plus_child_aggregation_budget_value_usd":3.805277574369502E7,
      "child-aggregation.budget.value-gbp":3.008838578E7,
      "child_aggregation_budget_value_gbp":3.008838578E7,
      "activity-plus-child-aggregation.budget.value-gbp":3.008838578E7,
      "activity_plus_child_aggregation_budget_value_gbp":3.008838578E7,
      "child-aggregation.outgoing-commitment.value":3.008838578E7,
      "child_aggregation_commitment_value":3.008838578E7,
      "activity-plus-child-aggregation.outgoing-commitment.value":3.008838578E7,
      "activity_plus_child_aggregation_commitment_value":3.008838578E7,
      "child-aggregation.outgoing-commitment.currency":"USD",
      "child_aggregation_commitment_currency":"USD",
      "activity-plus-child-aggregation.outgoing-commitment.currency":"USD",
      "activity_plus_child_aggregation_commitment_currency":"USD",
      "child-aggregation.outgoing-commitment.value-usd":3.805305421725511E7,
      "child_aggregation_commitment_value_usd":3.805305421725511E7,
      "activity-plus-child-aggregation.outgoing-commitment.value-usd":3.805305421725511E7,
      "activity_plus_child_aggregation_commitment_value_usd":3.805305421725511E7,
      "child-aggregation.outgoing-commitment.value-gbp":3.008838578E7,
      "child_aggregation_commitment_value_gbp":3.008838578E7,
      "activity-plus-child-aggregation.outgoing-commitment.value-gbp":3.008838578E7,
      "activity_plus_child_aggregation_commitment_value_gbp":3.008838578E7,
      "child-aggregation.disbursement.value":2.463636378E7,
      "child_aggregation_disbursement_value":2.463636378E7,
      "activity-plus-child-aggregation.disbursement.value":2.463636378E7,
      "activity_plus_child_aggregation_disbursement_value":2.463636378E7,
      "child-aggregation.disbursement.currency":"USD",
      "child_aggregation_disbursement_currency":"USD",
      "activity-plus-child-aggregation.disbursement.currency":"USD",
      "activity_plus_child_aggregation_disbursement_currency":"USD",
      "child-aggregation.disbursement.value-usd":3.2189819272862405E7,
      "child_aggregation_disbursement_value_usd":3.2189819272862405E7,
      "activity-plus-child-aggregation.disbursement.value-usd":3.2189819272862405E7,
      "activity_plus_child_aggregation_disbursement_value_usd":3.2189819272862405E7,
      "child-aggregation.disbursement.value-gbp":2.463636378E7,
      "child_aggregation_disbursement_value_gbp":2.463636378E7,
      "activity-plus-child-aggregation.disbursement.value-gbp":2.463636378E7,
      "activity_plus_child_aggregation_disbursement_value_gbp":2.463636378E7,
      "json.reporting-org":"{\"ref\": \"GB-GOV-10\", \"type\": 10, \"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}",
      "json.title":"{\"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP) phase III\", \"narrative.lang\": \" \"}",
      "json.description":["{\"type\": 1, \"narrative\": \"The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provides funding to the Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking which works to deliver new solutions to reduce the burden of poverty-related infectious diseases in sub-Saharan Africa and to strengthen research capacities to prepare and respond to re-emerging infectious diseases. Global Health EDCTP3 builds on EDCTP Phase 2, which NIHR has been contributing to since 2016 (GB-GOV-10-EDCTP2). As EDCTP transitions to Global Health EDCTP3, calls under the new work packages will support further clinical research and training in sub-Saharan Africa.\", \"narrative.lang\": \" \"}","{\"type\": 2, \"narrative\": \"The EU Strategic Research and Innovation Agenda (SRIA) for the Global Health EDCTP3 programme has two programmatic aims and five specific objectives for the 2021 to 2031 work programme. The programme aims to: (1) reduce the individual, social, and economic burdens of infectious diseases in sub-Saharan Africa through the development and uptake of new or improved interventions and (2) increase health security in sub-Saharan Africa and globally, particularly in the context of environmental change and the climate crisis, by reducing the risk of outbreaks and pandemics, and enhancing national and regional capacity to address antimicrobial resistance. Five specific objectives: 1) Advance biomedical interventions towards improved overall health, 2) Research capacity development, 3) Enhance coordination, 4) Strengthen capacity for epidemic preparedness and 5) build partnerships and strategic alliances. \", \"narrative.lang\": \" \"}"],
      "json.participating-org":["{\"ref\": \"GB-GOV-10\", \"role\": 1, \"type\": 10, \"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}","{\"ref\": \"GB-GOV-10\", \"role\": 2, \"type\": 10, \"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}","{\"ref\": \"GB-GOV-10\", \"role\": 3, \"type\": 10, \"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}"],
      "json.activity-date":["{\"iso-date\": \"2023-12-08\", \"type\": 1}","{\"iso-date\": \"2023-12-08\", \"type\": 2}","{\"iso-date\": \"2027-03-31\", \"type\": 3}"],
      "json.contact-info":["{\"type\": 1, \"organisation\": {\"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}, \"department\": {\"narrative\": \"Science, Research and Evidence\", \"narrative.lang\": \" \"}, \"person-name\": {\"narrative\": \"Global Health Research Programme\", \"narrative.lang\": \" \"}, \"email\": \"GlobalHealthResearch@dhsc.gov.uk\", \"website\": \"https://www.nihr.ac.uk/funding-and-support/global-health-research/\", \"mailing-address\": {\"narrative\": \"7th Floor South Wing, 39 Victoria Street, London, SW1H 0EU\", \"narrative.lang\": \" \"}}"],
      "json.recipient-region":["{\"code\": 298, \"vocabulary\": 1}"],
      "json.sector":["{\"code\": 12182, \"percentage\": 100, \"vocabulary\": 1, \"narrative\": \"Medical research\", \"narrative.lang\": \" \"}"],
      "json.tag":["{\"code\": \"RI\", \"vocabulary\": 99, \"vocabulary-uri\": \"https://devtracker.fcdo.gov.uk/custom-codes\", \"narrative\": \"Research and Innovation\", \"narrative.lang\": \" \"}"],
      "json.default-aid-type":["{\"code\": \"C01\"}"],
      "json.document-link":["{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/file/d/1gKjBMegVAsBuyERmpqiDEgK0C-dBGmxF/view?usp=drive_link\", \"title\": {\"narrative\": \"EDCTP Phase 2 and 3 2023-2025 Annual Review\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}, {\"code\": \"A02\"}, {\"code\": \"A05\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2025-05-26\"}]}","{\"format\": \"text/html\", \"url\": \"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2023-01-02?isExactMatch=true&status=31094501,31094502,31094503&callIdentifier=HORIZON-JU-GH-EDCTP3-2023-01&order=DESC&pageNumber=1&pageSize=50&sortBy=startDate\", \"title\": {\"narrative\": \"EDCTP3 Call for Proposals Tender\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A10\"}, {\"code\": \"A02\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2023-05-10\"}]}","{\"format\": \"text/html\", \"url\": \"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-01-05-two-stage\", \"title\": {\"narrative\": \"EDCTP3 EU Funding and Tenders Document\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A10\"}, {\"code\": \"A02\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-01-18\"}]}","{\"format\": \"text/html\", \"url\": \"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-01-06-two-stage\", \"title\": {\"narrative\": \"EDCTP3 EU Funding and Tenders Document\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A10\"}, {\"code\": \"A02\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-01-18\"}]}","{\"format\": \"text/html\", \"url\": \"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-02-01-two-stage\", \"title\": {\"narrative\": \"EDCTP3 EU Funding and Tenders Document\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A10\"}, {\"code\": \"A02\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-01-18\"}]}","{\"format\": \"text/html\", \"url\": \"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-ju-gh-edctp3-2024-mpox\", \"title\": {\"narrative\": \"EDCTP3 EU Funding and Tenders Document\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A10\"}, {\"code\": \"A02\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-01-18\"}]}","{\"format\": \"text/html\", \"url\": \"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2025-01-NTD-03-two-stage?order=DESC&pageNumber=1&pageSize=50&sortBy=startDate&keywords=edctp3&isExactMatch=true&status=31094501\", \"title\": {\"narrative\": \"EDCTP3 EU Funding and Tenders Document\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A10\"}, {\"code\": \"A02\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2015-01-30\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/file/d/1BZWPFcre_19ai3P9xy8nsVDF8dUQJh2J/view?usp=drive_link\", \"title\": {\"narrative\": \"EDCTP3 Strategy\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A02\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2022-01-12\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/open?id=1PdErJJpupm0rsFpEHypFzPd01LQ5LHLK&usp=drive_copy\", \"title\": {\"narrative\": \"Memorandum of Understanding\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A09\"}, {\"code\": \"A04\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2023-12-08\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/open?id=1wCyNw0EOM066OHrHcz1ITfLy3AezaK9K&usp=drive_copy\", \"title\": {\"narrative\": \"Memorandum of Understanding\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A09\"}, {\"code\": \"A04\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2023-09-21\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/file/d/1mles5md6uaJ9V1fuDBHrinEf9EY3LEVl/view?usp=drive_link\", \"title\": {\"narrative\": \"Memorandum of Understanding EDCTP 2+3\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A09\"}, {\"code\": \"A04\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2023-12-08\"}]}"],
      "json.related-activity":["{\"ref\": \"GB-GOV-10-EDCTP3_GlobalHealth\", \"type\": 2}","{\"ref\": \"GB-GOV-10-EDCTP3_PM\", \"type\": 2}"],
      "json.conditions":"{\"attached\": 0}",
      "related_budget_value":[9090909,9090909,9090909,88385,909091,909091,909091],
      "related_budget_period_start_quarter":[2,2,2,2,2,2,2],
      "related_budget_period_end_quarter":[1,1,1,1,1,1,1],
      "related_budget_period_start_iso_date":["2024-04-01T00:00:00Z","2025-04-01T00:00:00Z","2026-04-01T00:00:00Z","2023-04-01T00:00:00Z","2024-04-01T00:00:00Z","2025-04-01T00:00:00Z","2026-04-01T00:00:00Z"],
      "related_budget_period_end_iso_date":["2025-03-31T00:00:00Z","2026-03-31T00:00:00Z","2027-03-31T00:00:00Z","2024-03-31T00:00:00Z","2025-03-31T00:00:00Z","2026-03-31T00:00:00Z","2027-03-31T00:00:00Z"],
      "id":"30105dfa-8841-4b0c-9db7-5f82d4f8bf79",
      "related_activity_context":"ID: GB-GOV-10-EDCTP3\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase III\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provides funding to the Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking which works to deliver new solutions to reduce the burden of poverty-related infectious diseases in sub-Saharan Africa and to strengthen research capacities to prepare and respond to re-emerging infectious diseases. Global Health EDCTP3 builds on EDCTP Phase 2, which NIHR has been contributing to since 2016 (GB-GOV-10-EDCTP2). As EDCTP transitions to Global Health EDCTP3, calls under the new work packages will support further clinical research and training in sub-Saharan Africa.. The EU Strategic Research and Innovation Agenda (SRIA) for the Global Health EDCTP3 programme has two programmatic aims and five specific objectives for the 2021 to 2031 work programme. The programme aims to: (1) reduce the individual, social, and economic burdens of infectious diseases in sub-Saharan Africa through the development and uptake of new or improved interventions and (2) increase health security in sub-Saharan Africa and globally, particularly in the context of environmental change and the climate crisis, by reducing the risk of outbreaks and pandemics, and enhancing national and regional capacity to address antimicrobial resistance. Five specific objectives: 1) Advance biomedical interventions towards improved overall health, 2) Research capacity development, 3) Enhance coordination, 4) Strengthen capacity for epidemic preparedness and 5) build partnerships and strategic alliances. \n \n ID: GB-GOV-10-EDCTP3_GlobalHealth\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase III: The Global Health\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The European and Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.  This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase III (Global Health EDCTP3) programme (A7397_AA7398).. DHSC will support EDCTP3 activities in the fiscal year 2024-2025, which supports relevant Global Health EDCTP3 call topics and capacity strengthening under  agreed work programmes. Possible call topic areas include neglected tropical diseases, vector control, digital health and research training fellowships. \n \n ID: GB-GOV-10-EDCTP3_PM\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase III: funding for admin and programme management activities \nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking works to deliver new solutions to reduce the burden of poverty-related infectious diseases in sub-Saharan Africa and to strengthen research capacities to prepare and respond to re-emerging infectious diseases. EDCTP Members who have committed to participating in Global Health EDCTP3 are required to make an annual contribution to the EDCTP Association administrative costs. NIHR as a member provides a funding contribution to the EDCTP Association annual administrative costs and EDCTP 3 programme management activities. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase III (Global Health EDCTP3) programme (A7397_AA7398).. Support the European & Developing Countries Clinical Trials Partnership to effectively deliver EDCTP programmes to benefit people in sub-Saharan Africa. \n\n",
      "_version_":1866661299240304640
    }]
  }
}